Arginine homeostasis in allergic asthma

European Journal of Pharmacology

Volumn 585, Issue 2-3, 2008, Pages 375-384

  Maarsingh, Harm ^a   Zaagsma, Johan ^a   Meurs, Herman ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Airway hyperresponsiveness; Airway inflammation; Airway remodelling; Arginase; Cationic amino acid transporter; l arginine; l citrulline; Nitric oxide synthase; Peroxynitrite1

Indexed keywords

ALLERGEN; AMINO ACID TRANSPORTER; ARGINASE; ARGINASE INHIBITOR; ARGININE; CITRULLINE; ENZYME INHIBITOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; POLYAMINE; PROLINE;

ALLERGIC ASTHMA; DRUG BIOAVAILABILITY; DRUG MECHANISM; ENZYME ACTIVITY; EX VIVO STUDY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ARGININE; ASTHMA; BRONCHIAL HYPERREACTIVITY; CITRULLINE; HOMEOSTASIS; HUMANS; HYPERSENSITIVITY; INFLAMMATION;

EID: 43049119311     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.096     Document Type: Review

References (143)

1. Abe M., Hayashi Y., Murai A., Shibata K., Sakata N., Igarashi R., Katsuragi T., and Tanaka K. Effects of inducible nitric oxide synthase inhibitors on asthma depending on administration schedule. Free Radic. Biol. Med. 40 (2006) 1083-1095
2. Ahmed T., Garrigo J., and Danta I. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N. Engl. J. Med. 329 (1993) 90-95
3. Ahmed T., Syriste T., Mendelssohn R., Sorace D., Mansour E., Lansing M., Abraham W.M., and Robinson M.J. Heparin prevents antigen-induced airway hyperresponsiveness: interference with IP3-mediated mast cell degranulation?. J. Appl. Physiol. 76 (1994) 893-901
4. Ahmed T., Ungo J., Zhou M., and Campo C. Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides. J. Appl. Physiol. 88 (2000) 1721-1729
5. Albina J.E., Mahoney E.J., Daley J.M., Wesche D.E., Morris Jr. S.M., and Reichner J.S. Macrophage arginase regulation by CCAAT/enhancer-binding protein beta. Shock 23 (2005) 168-172
6. Al Qadi-Nassar B., Bichon-Laurent F., Portet K., Tramini P., Arnoux B., and Michel A. Effects of l-arginine and phosphodiesterase-5 inhibitor, sildenafil, on inflammation and airway responsiveness of sensitized BP2 mice. Fundam. Clin. Pharmacol. 21 (2007) 611-620
7. Bauer P.M., Fukuto J.M., Buga G.M., Pegg A.E., and Ignarro L.J. Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. Biochem. Biophys. Res. Commun. 262 (1999) 355-358
8. Bauer P.M., Buga G.M., Fukuto J.M., Pegg A.E., and Ignarro L.J. Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme. J. Biol. Chem. 276 (2001) 34458-34464
9. Belvisi M.G., Stretton C.D., Yacoub M., and Barnes P.J. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur. J. Pharmacol. 210 (1992) 221-222
10. Bergeron C., Boulet L.P., Page N., Laviolette M., Zimmermann N., Rothenberg M.E., and Hamid Q. Influence of cigarette smoke on the arginine pathway in asthmatic airways: increased expression of arginase I. J. Allergy Clin. Immunol. 119 (2007) 391-397
11. Boucher J.L., Moali C., and Tenu J.P. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for l-arginine utilization. Cell. Mol. Life Sci. 55 (1999) 1015-1028
12. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., and Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit Care Med. 161 (2000) 1720-1745
13. Boutard V., Havouis R., Fouqueray B., Philippe C., Moulinoux J.P., and Baud L. Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity. J. Immunol. 155 (1995) 2077-2084
14. Bowler S.D., Smith S.M., and Lavercombe P.S. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am. Rev. Respir. Dis. 147 (1993) 160-163
15. Ceyhan B., and Celikel T. Effect of inhaled heparin on methacholine-induced bronchial hyperreactivity. Chest 107 (1995) 1009-1012
16. Ceyhan B.B., and Celikel T. Effect of inhaled low molecular weight heparin on methacholine-induced bronchoconstriction. Int. J. Clin. Pharmacol. Ther. 38 (2000) 446-451
17. Chang K., Lee S.J., Cheong I., Billiar T.R., Chung H.T., Han J.A., Kwon Y.G., Ha K.S., and Kim Y.M. Nitric oxide suppresses inducible nitric oxide synthase expression by inhibiting post-translational modification of IkappaB. Exp. Mol. Med. 36 (2004) 311-324
18. Chen H., Macleod C., Deng B., Mason L., Kasaian M., Goldman S., Wolf S., Williams C., and Bowman M.R. CAT-2 amplifies the agonist-evoked force of airway smooth muscle by enhancing spermine-mediated phosphatidylinositol-(4)-phosphate-5-kinase-gamma activity. Am. J. Physiol., Lung Cell Mol. Physiol. 293 (2007) L883-L891
19. Cirino G., Fiorucci S., and Sessa W.C. Endothelial nitric oxide synthase: the Cinderella of inflammation?. Trends Pharmacol. Sci. 24 (2003) 91-95
20. Ckless K., Van V D., and Janssen-Heininger Y. Oxidative-nitrosative stress and post-translational protein modifications: implications to lung structure-function relations. Arginase modulates NF-kappaB activity via a nitric oxide-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 36 (2007) 645-653
21. Closs E.I., Simon A., Vekony N., and Rotmann A. Plasma membrane transporters for arginine. J. Nutr. 134 (2004) 2752S-2759S
22. Cook S., Vollenweider P., Menard B., Egli M., Nicod P., and Scherrer U. Increased eNO and pulmonary iNOS expression in eNOS null mice. Eur. Respir. J. 21 (2003) 770-773
23. Corraliza I.M., Soler G., Eichmann K., and Modolell M. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem. Biophys. Res. Commun. 206 (1995) 667-673
24. Cox J.D., Cama E., Colleluori D.M., Pethe S., Boucher J.L., Mansuy D., Ash D.E., and Christianson D.W. Mechanistic and metabolic inferences from the binding of substrate analogues and products to arginase. Biochemistry 40 (2001) 2689-2701
25. Coyle A.J., Ackerman S.J., and Irvin C.G. Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. Am. Rev. Respir. Dis. 147 (1993) 896-900
26. Coyle A.J., Uchida D., Ackerman S.J., Mitzner W., and Irvin C.G. Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation. Am. J. Respir. Crit Care Med. 150 (1994) S63-S71
27. Curis E., Nicolis I., Moinard C., Osowska S., Zerrouk N., Benazeth S., and Cynober L. Almost all about citrulline in mammals. Amino Acids 29 (2005) 177-205
28. Daniel E.E., Wang Y.F., Salapatek A.M., Mao Y.K., and Mori M. Arginosuccinate synthetase, arginosuccinate lyase and NOS in canine gastrointestinal tract: immunocytochemical studies. Neurogastroenterol. Motil. 12 (2000) 317-334
29. De Boer J., Meurs H., Coers W., Koopal M., Bottone A.E., Visser A.C., Timens W., and Zaagsma J. Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study. Br. J. Pharmacol. 119 (1996) 1109-1116
30. De Boer J., Duyvendak M., Schuurman F.E., Pouw F.M., Zaagsma J., and Meurs H. Role of l-arginine in the deficiency of nitric oxide and airway hyperreactivity after the allergen-induced early asthmatic reaction in guinea-pigs. Br. J. Pharmacol. 128 (1999) 1114-1120
31. De Boer J., Meurs H., Flendrig L., Koopal M., and Zaagsma J. Role of nitric oxide and superoxide in allergen-induced airway hyperreactivity after the late asthmatic reaction in guinea-pigs. Br. J. Pharmacol. 133 (2001) 1235-1242
32. De Gouw H.W., Verbruggen M.B., Twiss I.M., and Sterk P.J. Effect of oral l-arginine on airway hyperresponsiveness to histamine in asthma. Thorax 54 (1999) 1033-1035
33. Deves R., and Boyd C.A.R. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol. Rev. 78 (1998) 487-545
34. Diamant Z., Timmers M.C., Van V D., Page C.P., van der Meer F.J., and Sterk P.J. Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am. J. Respir. Crit Care Med. 153 (1996) 1790-1795
35. Dupont L.J., Rochette F., Demedts M.G., and Verleden G.M. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am. J. Respir. Crit Care Med. 157 (1998) 894-898
36. Durante W. Regulation of l-arginine transport and metabolism in vascular smooth muscle cells. Cell Biochem. Biophys. 35 (2001) 19-34
37. Durante W., Liao L., Iftikhar I., Cheng K., and Schafer A.I. Platelet-derived growth factor regulates vascular smooth muscle cell proliferation by inducing cationic amino acid transporter gene expression. J. Biol. Chem. 271 (1996) 11838-11843
38. Durante W., Liao L., Peyton K.J., and Schafer A.I. Thrombin stimulates vascular smooth muscle cell polyamine synthesis by inducing cationic amino acid transporter and ornithine decarboxylase gene expression. Circ. Res. 83 (1998) 217-223
39. Durante W., Liao L., Reyna S.V., Peyton K.J., and Schafer A.I. Transforming growth factor-beta(1) stimulates l-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis. Circulation 103 (2001) 1121-1127
40. Ellis J.L., and Conanan N. l-citrulline reverses the inhibition of nonadrenergic, noncholinergic relaxations produced by nitric oxide synthase inhibitors in guinea pig trachea and human bronchus. J. Pharmacol. Exp. Ther. 269 (1994) 1073-1078
41. Endo M., Oyadomari S., Terasaki Y., Takeya M., Suga M., Mori M., and Gotoh T. Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. Am. J. Physiol., Lung Cell. Mol. Physiol. 285 (2003) L313-L321
42. Erdely A., Kepka-Lenhart D., Clark M., Zeidler-Erdely P., Poljakovic M., Calhoun W.J., and Morris Jr. S.M. Inhibition of phosphodiesterase 4 amplifies cytokine-dependent induction of arginase in macrophages. Am. J. Physiol., Lung Cell. Mol. Physiol. 290 (2005) L534-L539
43. Ghosh T.K., Eis P.S., Mullaney J.M., Ebert C.L., and Gill D.L. Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin. J. Biol. Chem. 263 (1988) 11075-11079
44. Gotoh T., Araki M., and Mori M. Chromosomal localization of the human arginase II gene and tissue distribution of its mRNA. Biochem. Biophys. Res. Commun. 233 (1997) 487-491
45. Gray M.J., Poljakovic M., Kepka-Lenhart D., and Morris Jr. S.M. Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. Gene 353 (2005) 98-106
46. Greene A.L., Rutherford M.S., Regal R.R., Flickinger G.H., Hendrickson J.A., Giulivi C., Mohrman M.E., Fraser D.G., and Regal J.F. Arginase activity differs with allergen in the effector phase of ovalbumin- versus trimellitic anhydride-induced asthma. Toxicol. Sci. 88 (2005) 420-433
47. Griffith O.W., and Stuehr D.J. Nitric oxide synthases: properties and catalytic mechanism. Annu. Rev. Physiol. 57 (1995) 707-736
48. Hamad A.M., and Knox A.J. Mechanisms mediating the antiproliferative effects of nitric oxide in cultured human airway smooth muscle cells. FEBS Lett. 506 (2001) 91-96
49. Hammermann R., Hirschmann J., Hey C., Mossner J., Folkerts G., Nijkamp F.P., Wessler I., and Racke K. Cationic proteins inhibit l-arginine uptake in rat alveolar macrophages and tracheal epithelial cells. Implications for nitric oxide synthesis. Am. J. Respir. Cell Mol. Biol. 21 (1999) 155-162
50. Hammermann R., Hey C., Schafer N., and Racke K. Phosphodiesterase inhibitors and forskolin up-regulate arginase activity in rabbit alveolar macrophages. Pulm. Pharmacol. Ther. 13 (2000) 141-147
51. Hanazawa T., Kharitonov S.A., and Barnes P.J. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am. J. Respir. Crit Care Med. 162 (2000) 1273-1276
52. Hattori Y., Shimoda S., and Gross S.S. Effect of lipopolysaccharide treatment in vivo on tissue expression of argininosuccinate synthetase and argininosuccinate lyase mRNAs: relationship to nitric oxide synthase. Biochem. Biophys. Res. Commun. 215 (1995) 148-153
53. Hecker M., Nematollahi H., Hey C., Busse R., and Racke K. Inhibition of arginase by NG-hydroxy-l-arginine in alveolar macrophages: implications for the utilization of l-arginine for nitric oxide synthesis. FEBS Lett. 359 (1995) 251-254
54. Hey C., Boucher J.L., Vadon-Le Goff S., Ketterer G., Wessler I., and Racké K. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-d,l-indospicine, effects on l-arginine utilization by nitric oxide synthase. Br. J. Pharmacol. 121 (1997) 395-400
55. Hobbs C.A., and Gilmour S.K. High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation. J. Cell. Biochem. 77 (2000) 345-360
56. Hoet P.H., and Nemery B. Polyamines in the lung: polyamine uptake and polyamine-linked pathological or toxicological conditions. Am. J. Physiol., Lung Cell Mol. Physiol. 278 (2000) L417-L433
57. Husson A., Brasse-Lagnel C., Fairand A., Renouf S., and Lavoinne A. Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur. J. Biochem. 270 (2003) 1887-1899
58. Iizuka K., Yoshii A., Dobashi K., Horie T., Mori M., and Nakazawa T. InsP3, but not novel Ca2+ releasers, contributes to agonist-initiated contraction in rabbit airway smooth muscle. J. Physiol. 511 Pt 3 (1998) 915-933
59. Ito K., Caramori G., Lim S., Oates T., Chung K.F., Barnes P.J., and Adcock I.M. Expression and activity of histone deacetylases in human asthmatic airways. Am. J. Respir. Crit. Care Med. 166 (2002) 392-396
60. Jatakanon A., Lim S., Kharitonov S.A., Chung K.F., and Barnes P.J. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 53 (1998) 91-95
61. Jenkinson C.P., Grody W.W., and Cederbaum S.D. Comparative properties of arginases. Comp Biochem. Physiol. Part B Biochem. Mol. Biol. 114 (1996) 107-132
62. Kagemann G., Sies H., and Schnorr O. Limited availability of l-arginine increases DNA-binding activity of NF-kappaB and contributes to regulation of iNOS expression. J. Mol. Med. 85 (2007) 723-732
63. Kharitonov S.A., Yates D., Robbins R.A., Logan-Sinclair R., Shinebourne E.A., and Barnes P.J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343 (1994) 133-135
64. Kharitonov S., O'connor B.J., Evans D.J., and Barnes P.J. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am. J. Respir. Crit. Care Med. 151 (1995) 1894-1897
65. Kharitonov S.A., Lubec G., Lubec B., Hjelm M., and Barnes P.J. l-arginine increases exhaled nitric oxide in normal human subjects. Clin. Sci. (Lond.) 88 (1995) 135-139
66. Kharitonov S., Yates D.H., and Barnes P.J. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am. J. Respir. Crit. Care Med. 153 (1996) 454-457
67. Kitowska K., Zakrzewicz D., Konigshoff M., Chrobak I., Grimminger F., Seeger W., Bulau P., and Eickelberg O. Functional role and species-specific contribution of arginases in pulmonary fibrosis. Am. J. Physiol., Lung Cell. Mol. Physiol. 294 (2007) L34-L45
68. Klasen S., Hammermann R., Fuhrmann M., Lindemann D., Beck K.F., Pfeilschifter J., and Racke K. Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br. J. Pharmacol. 132 (2001) 1349-1357
69. Kochanski L., Kossmann S., Rogala E., and Dwornicki J. [Sputum arginase activity in bronchial asthma]. Pneumonol. Pol. 48 (1980) 329-332
70. Kurosawa M., Shimizu Y., Tsukagoshi H., and Ueki M. Elevated levels of peripheral-blood, naturally occurring aliphatic polyamines in bronchial asthmatic patients with active symptoms. Allergy 47 (1992) 638-643
71. Lee J., Ryu H., Ferrante R.J., Morris S.M., and Ratan R.R. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc. Nat. Acad. Sci. U. S. A. 100 (2003) 4843-4848
72. Lefort J., Nahori M.A., Ruffie C., Vargaftig B.B., and Pretolani M. In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs. J. Clin. Invest. 97 (1996) 1117-1121
73. Lewis C.C., Yang J.Y., Huang X., Banerjee S.K., Blackburn M.R., Baluk P., McDonald D.M., Blackwell T.S., Nagabhushanam V., Peters W., Voehringer D., and Erle D.J. Disease-specific gene expression profiling in multiple models of lung disease. Am. J. Respir. Crit Care Med. 177 (2007) 376-387
74. Li H., Romieu I., Sienra-Monge J.J., Ramirez-Aguilar M., Estela D.R.-N., Kistner E.O., Gjessing H.K., Lara-Sanchez I.C., Chiu G.Y., and London S.J. Genetic polymorphisms in arginase I and II and childhood asthma and atopy. J. Allergy Clin. Immunol. 117 (2006) 119-126
75. Lindemann D., and Racke K. Glucocorticoid inhibition of interleukin-4 (IL-4) and interleukin-13 (IL-13) induced up-regulation of arginase in rat airway fibroblasts. Naunyn Schmiedebergs Arch. Pharmacol. 368 (2003) 546-550
76. Louis C.A., Reichner J.S., Henry Jr. W.L., Mastrofrancesco B., Gotoh T., Mori M., and Albina J.E. Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. Am. J. Physiol. 274 (1998) R775-R782
77. Maarsingh H., Bossenga B.B., Bos I.S.T., Zaagsma J., and Meurs H. Arginase- and polycation-induced l-arginine limitation causes deficiency of bronchodilating NO and airway hyperreactivity after the late asthmatic reaction. Eur. Respir. J. 24 supl. 48 (2004) 681s
78. Maarsingh H., de Boer J., Kauffman H.F., Zaagsma J., and Meurs H. Heparin normalizes allergen-induced nitric oxide deficiency and airway hyperresponsiveness. Br. J. Pharmacol. 142 (2004) 1293-1299
79. Maarsingh H., Tio M.A., Zaagsma J., and Meurs H. Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation. Respir. Res. 6 (2005) 23
80. Maarsingh H., Leusink J., Bos I.S.T., Zaagsma J., and Meurs H. Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma. Respir. Res. 7 (2006) 6
81. Maarsingh H., Leusink J., Zaagsma J., and Meurs H. Role of the l-citrulline/l-arginine cycle in iNANC nerve-mediated nitric oxide production and airway smooth muscle relaxation in allergic asthma. Eur. J. Pharmacol. 546 (2006) 171-176
82. Maarsingh H., Volders H.H., Zaagsma J., and Meurs H. l-ornithine causes NO deficiency and airway hyperresponsiveness in perfused guinea pig tracheal preparations in vitr. Naunyn Schmiedebergs Arch. Pharmacol. 375 (2007) 151
83. Makinde T., Murphy R.F., and Agrawal D.K. The regulatory role of TGF-beta in airway remodeling in asthma. Immunol. Cell Biol. 85 (2007) 348-356
84. Marshall H.E., and Stamler J.S. Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40 (2001) 1688-1693
85. Mehta S., Drazen J.M., and Lilly C.M. Endogenous nitric oxide and allergic bronchial hyperresponsiveness in guinea pigs. Am. J. Physiol. 273 (1997) L656-L662
86. Messeri Dreissig M.D., Hammermann R., Mossner J., Gothert M., and Racke K. In rat alveolar macrophages lipopolysaccharides exert divergent effects on the transport of the cationic amino acids l-arginine and l-ornithine. Naunyn Schmiedebergs Arch. Pharmacol. 361 (2000) 621-628
87. Meurs H., Schuurman F.E., Duyvendak M., and Zaagsma J. Deficiency of nitric oxide in polycation-induced airway hyperreactivity. Br. J. Pharmacol. 126 (1999) 559-562
88. Meurs H., Hamer M.A., Pethe S., Vadon-Le Goff S., Boucher J.L., and Zaagsma J. Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity. Br. J. Pharmacol. 130 (2000) 1793-1798
89. Meurs H., McKay S., Maarsingh H., Hamer M.A., Macic L., Molendijk N., and Zaagsma J. Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br. J. Pharmacol. 136 (2002) 391-398
90. Meurs H., Maarsingh H., and Zaagsma J. Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol. Sci. 24 (2003) 450-455
91. Meurs H., Maarsingh H., and Zaagsma J. Nitric oxide and nitrogen oxides. In: Laurent G.J., and Shapiro S.D. (Eds). Encyclopedia of Respiratory Medicine (2006), Academic Press 161-169
92. Moali C., Boucher J.L., Sari M.A., Stuehr D.J., and Mansuy D. Substrate specificity of NO synthases: detailed comparison of l-arginine, homo-l-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-l-arginine. Biochemistry 37 (1998) 10453-10460
93. Modolell M., Corraliza I.M., Link F., Soler G., and Eichmann K. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 25 (1995) 1101-1104
94. Molinari J.F., Campo C., Shakir S., and Ahmed T. Inhibition of antigen-induced airway hyperresponsiveness by ultralow molecular-weight heparin. Am. J. Respir. Crit Care Med. 157 (1998) 887-893
95. Moncada S., Palmer R.M., and Higgs E.A. Biosynthesis of nitric oxide from l-arginine. A pathway for the regulation of cell function and communication. Biochem. Pharmacol. 38 (1989) 1709-1715
96. Morris S.M. Regulation of enzymes of the urea cycle and arginine metabolism. Annu. Rev. Nutr. 22 (2002) 87-105
97. Morris S.M. Arginine metabolism: boundaries of our knowledge. J. Nutr. 137 (2007) 1602S-1609S
98. Morris C.R., Poljakovic M., Lavrisha L., Machado L., Kuypers F.A., and Morris Jr. S.M. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am. J. Respir. Crit Care Med. 170 (2004) 148-153
99. Muijsers R.B., Van I A., Folkerts G., Koster A.S., Van Oosterhout A.J., Postma D.S., and Nijkamp F.P. Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in mice. Br. J. Pharmacol. 134 (2001) 434-440
100. Muijsers R.B., Van V D., Habernickel J., Folkerts G., Postma D.S., and Nijkamp F.P. Intra-luminal exposure of murine airways to peroxynitrite causes inflammation but not hyperresponsiveness. Inflamm. Res. 51 (2002) 33-37
101. Nagasaki A., Gotoh T., Takeya M., Yu Y., Takiguchi M., Matsuzaki H., Takatsuki K., and Mori M. Coinduction of nitric oxide synthase, argininosuccinate synthetase, and argininosuccinate lyase in lipopolysaccharide-treated rats. RNA blot, immunoblot, and immunohistochemical analyses. J. Biol. Chem. 271 (1996) 2658-2662
102. Nelin L.D., Chicoine L.G., Reber K.M., English B.K., Young T.L., and Liu Y. Cytokine-induced endothelial arginase expression is dependent on epidermal growth factor receptor. Am. J. Respir. Cell Mol. Biol. 33 (2005) 394-401
103. Nicholson B., Manner C.K., Kleeman J., and MacLeod C.L. Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J. Biol. Chem. 276 (2001) 15881-15885
104. Olson J.W., and Crooks P.A. Effect of nicotine and N¢-nitrosonornicotine on rat lung and trachea ornithine decarboxylase activity. Carcinogenesis 6 (1985) 1517-1519
105. Que L.G., Kantrow S.P., Jenkinson C.P., Piantadosi C.A., and Huang Y.C. Induction of arginase isoforms in the lung during hyperoxia. Am. J. Physiol. 275 (1998) L96-L102
106. Reczkowski R.S., and Ash D.E. Rat liver arginase: kinetic mechanism, alternate substrates, and inhibitors. Arch. Biochem. Biophys. 312 (1994) 31-37
107. Ricciardolo F.L.M. Multiple roles of nitric oxide in the airways. Thorax 58 (2003) 175-182
108. Ricciardolo F.L.M., DiMaria G.U., Mistretta A., Sapienza M.A., and Geppetti P. Impairment of bronchoprotection by nitric oxide in severe asthma. Lancet 350 (1997) 1297-1298
109. Ricciardolo F.L., Timmers M.C., Geppetti P., van Schadewijk A., Brahim J.J., Sont J.K., de Gouw H.W., Hiemstra P.S., van Krieken J.H., and Sterk P.J. Allergen-induced impairment of bronchoprotective nitric oxide synthesis in asthma. J. Allergy Clin. Immunol. 108 (2001) 198-204
110. Ricciardolo F.L., Sterk P.J., Gaston B., and Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 84 (2004) 731-765
111. Ricciardolo F.L., Zaagsma J., and Meurs H. The therapeutic potential of drugs targeting the arginase pathway in asthma. Expert. Opin. Investig. Drugs 14 (2005) 1221-1231
112. Rothenberg M.E., Doepker M.P., Lewkowich I.P., Chiaramonte M.G., Stringer K.F., Finkelman F.D., MacLeod C.L., Ellies L.G., and Zimmermann N. Cationic amino acid transporter 2 regulates inflammatory homeostasis in the lung. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 14895-14900
113. Rutschman R., Lang R., Hesse M., Ihle J.N., Wynn T.A., and Murray P.J. Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol. 166 (2001) 2173-2177
114. Sadeghi-Hashjin G., Folkerts G., Henricks P.A.J., Verheyen A.K.C.P., van der Linde H.J., Van Ark I., Coene A., and Nijkamp F.P. Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am. J. Respir. Crit Care Med. 153 (1996) 1697-1701
115. Saleh D., Ernst P., Lim S., Barnes P.J., and Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J. 12 (1998) 929-937
116. Samb A., Pretolani M., Dinh-Xuan A.T., Ouksel H., Callebert J., Lisdero C., Aubier M., and Boczkowski J. Decreased pulmonary and tracheal smooth muscle expression and activity of type 1 nitric oxide synthase (nNOS) after ovalbumin immunization and multiple aerosol challenge in guinea pigs. Am. J. Respir. Crit Care Med. 164 (2001) 149-154
117. Sandler N.G., Mentink-Kane M.M., Cheever A.W., and Wynn T.A. Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J. Immunol. 171 (2003) 3655-3667
118. Santing R.E., Hoekstra Y., Pasman Y., Zaagsma J., and Meurs H. The importance of eosinophil activation for the development of allergen-induced bronchial hyperreactivity in conscious, unrestrained guinea-pigs. Clin. Exp. Allergy 24 (1994) 1157-1163
119. Sapienza M.A., Kharitonov S.A., Horvath I., Chung K.F., and Barnes P.J. Effect of inhaled l-arginine on exhaled nitric oxide in normal and asthmatic subjects. Thorax 53 (1998) 172-175
120. Schapira R.M., Wiessner J.H., Morrisey J.F., Almagro U.A., and Nelin L.D. l-arginine uptake and metabolism by lung macrophages and neutrophils following intratracheal instillation of silica in vivo. Am. J. Respir. Cell Mol. Biol. 19 (1998) 308-315
121. Schuiling M., Meurs H., Zuidhof A.B., Venema N., and Zaagsma J. Dual action of iNOS-derived nitric oxide in allergen-induced airway hyperreactivity in conscious, unrestrained guinea pigs. Am. J. Respir. Crit Care Med. 158 (1998) 1442-1449
122. Schuiling M., Zuidhof A.B., Bonouvrie M.A., Venema N., Zaagsma J., and Meurs H. Role of nitric oxide in the development and partial reversal of allergen-induced airway hyperreactivity in conscious, unrestrained guinea-pigs. Br. J. Pharmacol. 123 (1998) 1450-1456
123. Sharkhuu T., Matthaei K.I., Forbes E., Mahalingam S., Hogan S.P., Hansbro P.M., and Foster P.S. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin. Exp. Allergy 36 (2006) 1575-1583
124. Shuttleworth C.W., Burns A.J., Ward S.M., O'Brien W.E., and Sanders K.M. Recycling of l-citrulline to sustain nitric oxide-dependent enteric neurotransmission. Neuroscience 68 (1995) 1295-1304
125. Sparkes R.S., Dizikes G.J., Klisak I., Grody W.W., Mohandas T., Heinzmann C., Zollman S., Lusis A.J., and Cederbaum S.D. The gene for human liver arginase (ARG1) is assigned to chromosome band 6q23. Am. J. Hum. Genet. 39 (1986) 186-193
126. Takano H., Lim H.B., Miyabara Y., Ichinose T., Yoshikana T., and Sagai M. Oral administration of l-arginine potentiates allergen-induced airway inflammation and expression of interleukin-5 in mice. J. Pharmacol. Exp. Ther. 286 (1998) 767-771
127. Takemoto K., Shibamori M., Hitomi Y., Takigawa T., Wang D.H., Ichimura H., Fujikura Y., and Ogino K. Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma. Am. J. Physiol., Lung Cell Mol. Physiol. 293 (2007) L1419-L1426
128. Ten Broeke R., De C.R., Van H.R., Verweij V., Leusink-Muis T., Van I A., De C.F., Nijkamp F.P., and Folkerts G. Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. Respir. Res. 7 (2006) 58
129. Thomassen M.J., Buhrow L.T., Connors M.J., Kaneko F.T., Erzurum S.C., and Kavuru M.S. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 17 (1997) 279-283
130. Thyberg J., and Fredholm B.B. Induction of ornithine decarboxylase activity and putrescine synthesis in arterial smooth-muscle cells stimulated with platelet-derived growth-factor. Exp. Cell Res. 170 (1987) 160-169
131. Thyberg J., and Fredholm B.B. Modulation of arterial smooth-muscle cells from contractile to synthetic phenotype requires induction of ornithine decarboxylase activity and polyamine synthesis. Exp. Cell Res. 170 (1987) 153-159
132. Tucker J.F., Brave S.R., Charalambous L., Hobbs A.J., and Gibson A. l-NG-nitro arginine inhibits non-adrenergic, non-cholinergic relaxations of guinea-pig isolated tracheal smooth muscle. Br. J. Pharmacol. 100 (1990) 663-664
133. Uchida D.A., Ackerman S.J., Coyle A.J., Larsen G.L., Weller P.F., Freed J., and Irvin C.G. The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. Am. Rev. Respir. Dis. 147 (1993) 982-988
134. Van Geldre L.A., Timmermans J.P., and Lefebvre R.A. l-citrulline recycling by argininosuccinate synthetase and lyase in rat gastric fundus. Eur. J. Pharmacol. 455 (2002) 149-160
135. Wardlaw A.J., Dunnette S., Gleich G.J., Collins J.C., and Kay A. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild ashtma. Am. Rev. Respir. Dis. 137 (1988) 62-69
136. Waugh W.H., Daeschner III C.W., Files B.A., McConnell M.E., and Strandjord S.E. Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results. J. Natl. Med. Assoc. 93 (2001) 363-371
137. Wei L.H., Jacobs A.T., Morris Jr. S.M., and Ignarro L.J. IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am. J. Physiol., Cell Physiol. 279 (2000) C248-C256
138. Wu G., and Morris S.M. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336 (1998) 1-17
139. Xia Y., and Zweier J.L. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6954-6958
140. Xia Y., Roman L.J., Masters B.S., and Zweier J.L. Inducible nitric-oxide synthase generates superoxide from the reductase domain. J. Biol. Chem. 273 (1998) 22635-22639
141. Yahata T., Nishimura Y., Maeda H., and Yokoyama M. Modulation of airway responsiveness by anionic and cationic polyelectrolyte substances. Eur. J. Pharmacol. 434 (2002) 71-79
142. Yang M., Rangasamy D., Matthaei K.I., Frew A.J., Zimmmermann N., Mahalingam S., Webb D.C., Tremethick D.J., Thompson P.J., Hogan S.P., Rothenberg M.E., Cowden W.B., and Foster P.S. Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J. Immunol. 177 (2006) 5595-5603
143. Zimmermann N., King N.E., Laporte J., Yang M., Mishra A., Pope S.M., Muntel E.E., Witte D.P., Pegg A.A., Foster P.S., Hamid Q., and Rothenberg M.E. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J. Clin. Invest. 111 (2003) 1863-1874